Stockscreener 앱 받기
0.46%
시간 외 거래:
Pfizer Inc 주식(PFE)의 최신 뉴스
The Zacks Analyst Blog Highlights Pfizer, Altria, Newmont, Koil Energy and Stratus Properties - Yahoo Finance Singapore
Top Research Reports for Pfizer, Altria & Newmont Corp. - Yahoo Finance
Pfizer Inc. Stock (US7170811035): Analyst Views And Valuation In Focus After Quiet Start To The Week - AD HOC NEWS
Investors heavily search Pfizer Inc. (PFE): Here is what you need to know - MSN
Dr Reddy’s challenges Pfizer with US launch of Bosutinib - The Pharma Letter
Bio Usawa Appoints Dr. Aida Habtezion, Former Chief Medical Officer at Pfizer, to its Board of Directors - Yahoo Finance Singapore
SINOPHARM (01099.HK) Establishes Strategic Partnership with Pfizer, Inc. (PFE.US) - AASTOCKS.com
Pfizer Obesity Pipeline Gains Traction As Berobenatide Data Support Valuation - Yahoo Finance
Pfizer Holds Near $26, Dividend Draws Watch as Drug Prices Cloud Outlook - TechStock²
Comirnaty (Original/Omicron XBB.1.5): Updated mRNA COVID-19 vaccine in focus for US adults - AD HOC NEWS
Pfizer Inc. Stock (US7170811035): Analyst Views and Valuation Under the Microscope - AD HOC NEWS
Pfizer (PFE) Upgraded at RBC Capital. Here is Why - Insider Monkey
How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take. - The Motley Fool
Pfizer trades around $26 with dividend in focus, drug-price worries linger - TechStock²
Pfizer Pivots Hard: Obesity, Cancer Bets Tempt Investors - TipRanks
Insider trades: Microsoft, Tesla, Pfizer among notable names - Seeking Alpha
Pfizer (PFE): The Best Longevity Stock to Buy Now - Insider Monkey
Pfizer Draws Fresh Focus As Growth Strategy Evolves - Kalkine Media
Pfizer (PFE) Stock Valuation Check As Modest Recent Gains Meet Mixed Multi Year Returns - simplywall.st
Dividend HistoryPfizer (PFE) - Zacks Investment Research
Pfizer Draws Fresh Attention As Pipeline Activity Accelerates - Kalkine Media
Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About - Yahoo Finance
Pfizer Still Trades Over $26 as RBC Lift Balances Out Drug-Pricing Concerns - TechStock²
ORIC gains as Stifel resumes at Buy on upcoming Pfizer readout - Seeking Alpha
SpaceX IPO: Value Investors Warn You're Buying A StoryPfizer (NYSE:PFE), SpaceX (NASDAQ:SPCX) - Benzinga
Pfizer Oncology Data Underscore Survival Gains And Valuation Debate - Yahoo Finance
US legislation targets China pharma IP licensing following multi-billion Pfizer, BMS deals - IAM Patent
Sector Gamma AS Sells 392,547 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Stake Lowered by Swiss National Bank - MarketBeat
Pfizer Inc. $PFE Shares Sold by Te Ahumairangi Investment Management Ltd - MarketBeat
Kovack Advisors Inc. Buys 64,044 Shares of Pfizer Inc. $PFE - MarketBeat
ICICI Prudential Asset Management Co Ltd Has $4.11 Million Stock Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Purchased by IFM Investors Pty Ltd - MarketBeat
Alps Advisors Inc. Sells 57,526 Shares of Pfizer Inc. $PFE - MarketBeat
First Financial Bankshares Inc Sells 54,776 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Purchased by Aviva PLC - MarketBeat
Pfizer Inc. (NYSE:PFE) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Does New GLP‑1 Data And HYMPAVZI Expansion Reshape The Bull Case For Pfizer (PFE)? - simplywall.st
Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Pfizer (NYSE:PFE) Shares Up 2.2%Here's What Happened - MarketBeat
Pfizer Inc. stock outperforms competitors on strong trading day - MarketWatch
PFE Stock Quote Price and Forecast - CNN
This $25 Billion Acquisition Just Unlocked a New Era of Growth for Pfizer — and Why It’s a Flawless Safe-Haven for Retirees - Yahoo Finance
A Sizzling 6.7% Dividend Yield? 1 Under-the-Radar Reason I Am Holding Off on Pfizer Stock at $25 - Yahoo Finance
Pfizer’s New Phase 1 PF-07799544 Study Adds Quiet Depth to Its R&D Pipeline - TipRanks
Why Pfizer Stock Popped Today - The Globe and Mail
Pfizer Shares Edge Higher on RBC Upgrade, German Pricing Risk in Focus - TechStock²
Lexicon Pharmaceuticals vs Pfizer: Comparing a Small Biotech with a Global DrugmakerNews and Statistics - IndexBox
Pfizer shares climb 3.2% as investors digest expanded U.S. label for HYMPAVZI - Quiver Quantitative
Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026? - Yahoo Finance
Pfizer Inc. $PFE Stock Position Lowered by Townsquare Capital LLC - MarketBeat
Insider Sell: Jennifer Damico Sells 2,000 Shares of Pfizer Inc (PFE) - GuruFocus
Veteran Analyst Revamps Pfizer Stock Price Target for Rest of 2026 - TradingView
Roche and Pfizer race to lead obesity and diabetes drug market with promising new treatments. - Pluang
Roche Vs. Pfizer: Obesity Week Presentations Deep DiveWhat Investors Must Know (RHHBY) - Seeking Alpha
Pfizer Steps Up in Obesity Race With New Mid-Stage SOLIS-1 Trial - TipRanks
Pfizer pulls out of summit with Germany's Merz over health care reform - Yahoo Finance
Pfizer CEO warns German investment at risk over drug pricing policies - Reuters
Pfizer's 2025 Impact Report Highlights Progress Across Patients, Planet, and Responsible Business - Pfizer
Pfizer Stock 2026: CEO Lays Out the Case for a Growth Surge - TIKR.com
Pfizer upgraded at RBC Capital Markets on risk-reward setup - MSN
Pfizer stock upgraded at RBC Capital Markets (PFE:NYSE) - Seeking Alpha
Wills Financial Group LLC Increases Stake in Pfizer Inc. $PFE - MarketBeat
Letko Brosseau & Associates Inc. Sells 160,000 Shares of Pfizer Inc. $PFE - MarketBeat
Analyst recommendations: Nike, Pfizer, Hewlett Packard, Intel, The Trade Desk… - marketscreener.com
1.40%
0.23%
자본화:
|
볼륨(24시간):